MedPath

Study of PPAR-gamma activating effect of angiotensin II receptor antagonist, telmisarta

Not Applicable
Conditions
Hypertension
Registration Number
JPRN-UMIN000014248
Lead Sponsor
Jichi Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
43
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients treated with Ca-channel blockers (excluded amlodipine), ARB, angiotensin converting enzyme inhibitors, statin, anti-diabetic drugs, beta-blockers or thiazide diuretics 2) Patients with hypersensitivity to the drug contents 3) Pregnant women 4) Patients with severe renal dysfunction 5) Patients with secondary hypertension 6) Patients who are disqualified by the doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath